A key hallmark of malignant tissues is a metabolic shift from oxidative phosphorylation to glycolytic metabolism, leading to increased lactate production. Probing the kinetics of lactate production in vivo may play a key role in studying disease mechanisms and developing biomarkers of treatment response. Here, we developed a new approach for studying glycolytic metabolism in glioblastoma by combining 1H MRS with infusion of deuterated glucose. Infusion of [6,6'-2H2]glucose leads to downstream deuterium labeling of lactate, resulting in a reduction in the 1.33 ppm lactate peak on 1H MRS and making it is possible to monitor the metabolic turnover of lactate.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords